Trial Profile
Quetiapine (Seroquel) maintenance treatment in early onset bipolar spectrum disorders: an open prospective longitudinal study of the effectiveness of quetiapine monotherapy in preventing relapse and minimizing neurocognitive dysfunction among adolescents manifesting bipolar spectrum disorders
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar disorders
- Focus Therapeutic Use
- 03 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2006 New trial record.